Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Pharmaceutical Flow Cytometry & Imaging Show

10 Oct 2012 - 11 Oct 2012 - AstraZeneca Conference Centre, AstraZeneca R&D Alderley Park, UK



Bookmark and Share


Following on from the great success and positive feedback from our previous meetings, we are continuing to include topics of current interest by adding Phenotypic Screening and Personalised Health Care to the areas that will be addressed.  Typical attendees will be colleagues from small-to mid-sized biotech companies, contract research organisations and global pharmaceutical companies. The content of this free two day meeting will also include other industrial-based themes covering the drug development journey from discovery to clinical evaluation.

Topics over two days will include:

Lead Generation - high throughput / high content screening
Pharmaceuticals - monoclonal antibodies and fragments 
Drug attrition - safety and secondary pharmacology
Stem cells - range of application in discovery research and therapy
Biomarkers - method validation, clinical study support & outsourcing of cell-based assays
New techniques and applications - novel agents, instruments and analysis
Phenotypic Screening - complex and cell based assays
Personalised Health Care - decision making biomarkers, companion diagnostics & life-cycle management

Posters - Submit an Abstract to:  posters@elrig.org
Exhibition Trade Show - Book your stand at www.elrig.org
2 Days Scientific Sessions - Leaders in Flow and Imaging will be presenting

Register and Attend FREE OF CHARGE go to: www.elrig.org


Further information
Scientific News
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Newfound Strength in Regenerative Medicine
A promising new approach uses direct mechanical stimulation to repair severely damaged skeletal muscles.
Mapping out Cell Conversion
Researchers develop algorithm that takes the field of cell reprogramming forward.
Donor's Genotype Controls the Differentiation of IPS Cells
Pluripotent stem cells derived from different cell types are equally susceptible to reprogramming, indicates a recent study by the University of Helsinki and the National Institute for Health and Welfare, Finland. However, the genotype of the donor strongly influences the differentiation of the stem cell.
Signals That Make Early Stem Cells Identified
Researchers at The Rockefeller University have identified a new mechanism by which cells are instructed during development to become stem cells
Healing Scarred Hearts
Findings suggest stem cells may one day be used to regenerate damaged tissue after heart attack.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!